Nakae H, Endo S, Inada K, Watanabe M, Baba N, Yoshida M
Critical Care and Emergency Center, Iwate Medical University, Morioka, Japan.
Res Commun Mol Pathol Pharmacol. 1994 Oct;86(1):37-42.
To examine the roles of leukotriene B4 (LTB4) and prostaglandin I2 (PGI2), the metabolites of arachidonic acid found in patients with sepsis, we measured the serum levels of LTB4 and a stable metabolite of PGI2, 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha), in 22 patients with sepsis. Results were analyzed in relation to patients' survival. The serum levels of both LTB4 and 6-keto-PGF1 alpha were significantly higher in patients who died than in those who survived, thus serving as indicators of illness severity. There was a significant correlation between LTB4 and 6-keto-PGF1 alpha levels. The present study suggests that LTB4, a potent leukocyte activator, induces damage to vascular endothelial cells in patients with sepsis, resulting in the excessive production of PGI2 and, consequently, serious illness.
为了研究白三烯B4(LTB4)和前列腺素I2(PGI2)(这两种花生四烯酸代谢产物在脓毒症患者体内可检测到)的作用,我们检测了22例脓毒症患者血清中LTB4和PGI2的稳定代谢产物6-酮-前列腺素F1α(6-酮-PGF1α)的水平。分析结果与患者的生存率相关。死亡患者血清中LTB4和6-酮-PGF1α水平均显著高于存活患者,因此可作为疾病严重程度的指标。LTB4和6-酮-PGF1α水平之间存在显著相关性。本研究表明,强效白细胞激活剂LTB4可导致脓毒症患者血管内皮细胞损伤,从而导致PGI2过度产生,进而引发严重疾病。